BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6157308)

  • 1. Calmodulin release from striatal membranes after acute and chronic treatment with butaclamol.
    Gnegy ME; Lau YS
    Adv Biochem Psychopharmacol; 1980; 24():147-51. PubMed ID: 6157308
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of chronic and acute treatment of antipsychotic drugs on calmodulin release from rat striatal membranes.
    Gnegy ME; Lau YS
    Neuropharmacology; 1980 Mar; 19(3):319-23. PubMed ID: 6158710
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic sulpiride increased 3H-spiperone binding and calmodulin dependent phosphorylation in rat striatum.
    Lau YS; Runice C; Dowd FJ; Anene C
    Proc West Pharmacol Soc; 1983; 26():139-43. PubMed ID: 6310625
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity.
    Lau YS; Runice C; Dowd F
    J Pharmacol Exp Ther; 1984 Apr; 229(1):32-7. PubMed ID: 6323689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal neuroleptic exposure alters postnatal striatal cholinergic activity in the rat.
    Miller JC; Friedhoff AJ
    Dev Neurosci; 1986; 8(2):111-6. PubMed ID: 2427306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol and MK-801 block increases in striatal calmodulin resulting from repeated amphetamine treatment.
    Gnegy ME; Hewlett GH; Pimputkar G
    Brain Res; 1996 Sep; 734(1-2):35-42. PubMed ID: 8896805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic haloperidol treatment increased calcium-dependent phosphorylation in rat striatum.
    Lau YS; Gnegy ME
    Life Sci; 1982 Jan; 30(1):21-8. PubMed ID: 6275231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]dihydroergocryptine binding to bovine striatal membranes defined by a low d-butaclamol concentration: antagonism by substituted benzamides.
    Lin CW; Maayani S; Wilk S
    Biochem Pharmacol; 1981 Jun; 30(11):1305-14. PubMed ID: 6168265
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of chlorine substituents on the benzene rings of an analogue of the antipsychotic drug butaclamol on the interaction with dopamine and muscarinic receptors in rat brain.
    Pugsley TA; Lippmann W
    J Pharm Pharmacol; 1979 Jan; 31(1):47-9. PubMed ID: 32368
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of opioids on striatal calmodulin levels.
    Clouet DH; Williams N
    Life Sci; 1982 Nov 15-22; 31(20-21):2283-6. PubMed ID: 7162344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine agonists stimulate protein carboxylmethylation in striatal synaptosomes.
    Billingsley ML; Roth RH
    J Pharmacol Exp Ther; 1982 Dec; 223(3):681-8. PubMed ID: 6183421
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of structural analogs of butaclamol (a new antipsychotic drug) on striatal homovanillic acid and adenyl cyclase of olfactory tubercle in rats.
    Pugsley TA; Merker J; Lippman W
    Can J Physiol Pharmacol; 1976 Aug; 54(4):510-5. PubMed ID: 10057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of calmodulin on dopamine-sensitive adenylate cyclase activity in rat striatal membranes.
    Gnegy M; Treisman G
    Mol Pharmacol; 1981 Mar; 19(2):256-63. PubMed ID: 7231389
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding of 3H-lisuride hydrogen maleate to striatal membranes of rat brain.
    Fujita N; Saito K; Yonehara N; Watanabe Y; Yoshida H
    Life Sci; 1979 Sep; 25(11):969-73. PubMed ID: 513944
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of calmodulin, troponin, and cyclic AMP in the regulation of glycogen metabolism in mammalian skeletal muscle.
    Cohen P
    Adv Cyclic Nucleotide Res; 1981; 14():345-59. PubMed ID: 6269387
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulsatile growth hormone and prolactin: effects of (+) butaclamol, a dopamine receptor blocking agent.
    Willoughby JO; Brazeau P; Martin JB
    Endocrinology; 1977 Oct; 101(4):1298-303. PubMed ID: 908278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACTH-stimulated changes in the immunocytochemical localization of cyclic nucleotides, protein kinases, and calmodulin.
    Harper JF; Wallace RW; Cheung WY; Steiner AL
    Adv Cyclic Nucleotide Res; 1981; 14():581-91. PubMed ID: 6269401
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of lanthanum and trifluoperazine on [125I]calmodulin binding to rat striatal particulates.
    Lau YS; Gnegy ME
    J Pharmacol Exp Ther; 1980 Oct; 215(1):28-34. PubMed ID: 7452489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cyclic AMP- and Ca-dependent phosphorylation of functionally significant proteins in presynaptic structures].
    Glebov RN
    Usp Sovrem Biol; 1981; 91(3):433-50. PubMed ID: 6270926
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential reduction of morphine-withdrawal body shakes by butaclamol enantiomers.
    Hynes MD; McCarten MD; Shearman G; Lal H
    Life Sci; 1978 Jan; 22(1):133-6. PubMed ID: 564436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.